BARD Score — Advanced Fibrosis in NAFLD

Calculate the BARD Score using BMI, AST/ALT ratio, and diabetes to predict advanced hepatic fibrosis in non-alcoholic fatty liver disease as a simple clinical bedside tool.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculate the BARD Score using BMI, AST/ALT ratio, and diabetes to predict advanced hepatic fibrosis in non-alcoholic fatty liver disease as a simple clinical bedside tool

Each component has a specific meaning:

  • BMI — The bmi recorded for the scenario being assessed.
  • AST/ALT ratio — The ast/alt ratio recorded for the scenario being assessed.
  • Diabetes — The diabetes recorded for the scenario being assessed.

Note: Interpret the bard score result against the thresholds and context described above.

How to Use

Enter the BMI, AST/ALT ratio, diabetes for the scenario you are assessing. Calculate the BARD Score using BMI, AST/ALT ratio, and diabetes to predict advanced hepatic fibrosis in non-alcoholic fatty liver disease as a simple clinical bedside tool. Use the bard score result to inform your calculation.

Frequently Asked Questions